Melanoma kills by spreading from the skin to vital organs, where growing tumors destroy normal tissue and eventually cause those organs to fail. A small, thin melanoma on the skin itself is not life-threatening. The danger comes when melanoma cells enter the lymphatic system or bloodstream and establish new tumors (metastases) in the lungs, liver, brain, or other organs. Once melanoma reaches distant organs, the five-year survival rate is around 31% with modern immunotherapy treatments, up from 14% before these therapies became available around 2015.
How Melanoma Spreads Beyond the Skin
Melanoma cells can travel through two main routes: the lymphatic system and the bloodstream. The most common first stop is the nearby lymph nodes, with about 50% of people who develop metastases showing lymph node involvement as their first sign of spread. But melanoma can also skip the lymph nodes entirely. Roughly 30% of people with metastatic melanoma develop tumors in distant organs without any detectable lymph node disease, meaning the cancer cells traveled directly through the bloodstream.
Once in the blood, melanoma cells can land almost anywhere. The lungs, liver, brain, and bone are the most common destinations, though melanoma has been found in the heart, kidneys, and bladder as well. What makes melanoma particularly dangerous compared to many other skin cancers is this tendency to spread widely and unpredictably, sometimes years after the original mole was removed.
Organ Failure From Tumor Growth
The core mechanism of death in most melanoma cases is organ failure. Metastatic tumors physically replace healthy tissue, compress blood vessels, and block the normal function of whatever organ they’ve colonized. The specific way this plays out depends on where the cancer has spread.
Liver
When melanoma infiltrates the liver, it can replace so much normal tissue that the liver can no longer perform its essential jobs: filtering toxins, producing clotting factors, regulating blood sugar, and processing nutrients. In documented cases, melanoma-infiltrated livers have swollen to enormous sizes, with tumors compressing the major veins that drain blood from the liver and even obliterating portions of the large vein that returns blood to the heart. A liver biopsy in one such case revealed almost no normal liver tissue remaining, with the organ nearly entirely replaced by tumor.
As liver function collapses, a cascade of problems follows. Toxins build up in the blood, causing confusion and eventually unconsciousness. The kidneys begin to fail. Blood sugar drops dangerously low because the liver can no longer release stored glucose. Acid accumulates in the blood. Clotting breaks down, raising the risk of internal bleeding. This progression from liver infiltration to multi-organ shutdown can happen rapidly, sometimes over just days to weeks.
Lungs
Melanoma in the lungs grows as nodules that crowd out the air sacs responsible for oxygen exchange. As more lung tissue is replaced or compressed, breathing becomes increasingly difficult. Fluid can also accumulate around the lungs, further reducing their capacity. Eventually, the body cannot take in enough oxygen or expel enough carbon dioxide to sustain itself.
Brain
Brain metastases are especially common with melanoma and particularly dangerous. The skull is a fixed space, so growing tumors increase pressure inside it, damaging surrounding brain tissue. Depending on location, brain metastases can cause seizures, loss of motor control, personality changes, severe headaches, and eventually coma. Swelling around brain tumors can also block the flow of cerebrospinal fluid, creating a life-threatening buildup of pressure.
Cachexia: The Body Consuming Itself
Even before a single organ fails completely, advanced melanoma can trigger a devastating whole-body syndrome called cachexia. This is severe, progressive muscle and fat loss that cannot be reversed simply by eating more. It affects most people with advanced cancer and is a direct cause of death in a significant percentage of them.
Cachexia works through a combination of two forces. First, the cancer and the body’s inflammatory response to it suppress appetite, so food intake drops. People with advanced cancer and systemic inflammation often eat far less than their bodies need. Second, and more importantly, the tumor releases substances that fundamentally alter metabolism. These signals break down fat stores by accelerating the release of fatty acids into the bloodstream, and they drive muscle wasting even when some nutrition is available. Researchers have described cachexia as a state of “autocannibalism,” where the tumor essentially survives at the expense of the host.
What makes cachexia particularly cruel is that the tumor itself doesn’t need to be large to cause it. In humans, the tumor burden is often less than 1% of body weight when profound wasting is already underway. The damage comes not from the tumor physically consuming resources, but from the metabolic signals it sends throughout the body. The result is progressive weakness, immune suppression, and a body increasingly unable to withstand the stress of the disease.
How the Immune System Loses Control
Melanoma is one of the most immunologically active cancers, meaning the immune system often recognizes it as a threat. This is actually why immunotherapy works so well for some patients. But untreated or treatment-resistant melanoma eventually overwhelms immune defenses through several strategies. Tumor cells can produce signals that tell nearby immune cells to stand down. They can also recruit regulatory immune cells that actively suppress anti-tumor responses. As the disease advances and cachexia sets in, the immune system weakens further, leaving the body vulnerable not only to the cancer itself but to infections that a healthy immune system would handle easily. Pneumonia and sepsis are common contributors to death in people with advanced melanoma.
Why Timing Matters So Much
The difference between melanoma as a curable skin cancer and melanoma as a fatal disease comes down almost entirely to how deep and how far it has spread at the time of detection. A melanoma caught while it is still thin and confined to the upper layers of skin has a five-year survival rate above 99%. Once it has reached distant organs, that number drops to 31% even with the best current treatments. The median survival for stage IV melanoma is now about 15 months with immunotherapy, compared to roughly 8 months before these drugs existed.
Immunotherapy has changed the landscape significantly. Some patients with metastatic melanoma achieve long-term remission, with their immune systems keeping the cancer in check for years. But for those whose cancer does not respond to treatment or eventually develops resistance, the progression from metastasis to organ failure and cachexia remains the path by which melanoma ultimately proves fatal.